Oligomerix is seeking solutions to major unmet medical needs with over 10 years research experience in helping define the role of tau protein in neurodegenerative diseases and discovering and developing novel therapeutics for Alzheimer’s and related tauopathies.
Role of tau protein in Alzheimer’s disease:
This video shows how the loss of tau protein function leads to structural changes causing the loss of communication between neurons, a defining characteristic of Alzheimer’s disease.Oligomerix has further found that tau acquires toxic functions degrading proteins and disrupting memory formation when it forms small soluble aggregates of tau, tau oligomers.
We are discovering therapeutics that target tau protein loss of function and gain of toxicity
May 2, 2016
Oligomerix Awarded a Grant for its Alzheimer’s Drug…
January 14, 2014
Oligomerix Relocates Corporate Headquarters and Secures…
January 3, 2014
Oligomerix to Present at Biotech ShowcaseTM 2014…
December 9, 2013
Taconic and Oligomerix to Collaborate on Tau Mouse Model …